STAND. COM. REP. NO. 1312

 

Honolulu, Hawaii

, 2019

 

RE: S.B. No. 807

S.D. 1

H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2019

State of Hawaii

 

Sir:

 

Your Committee on Health, to which was referred S.B. No. 807, S.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

 

begs leave to report as follows:

 

The purpose of this measure is to:

 

(1) Specify that health care providers shall not be required to consult the electronic prescription accountability system before prescribing controlled substances:

 

(A) Administered directly to hospital inpatients under the supervision of a health care provider licensed to practice within the State;

 

(B) As an initial prescription for a patient being treated for post-operative pain, provided the prescription is limited to a three-day supply; and

 

(C) For patients with a terminal disease receiving hospice or other types of palliative care; and

 

(2) Specify that an informed consent agreement is not required for opioid therapy patients who are incapacitated and receiving treatment at a hospital under the supervision of a licensed health care provider.

 

The Department of Health, Department of Public Safety, Hawaii Health Systems Corporation, Oahu County Committee on Legislative Priorities of the Democratic Party of Hawaii, and an individual testified in support of this measure. The Hawaii State Center for Nursing, Hawaii Pacific Health, Healthcare Association of Hawaii, Kaiser Permanente Hawaii, Hawaii Medical Association, The Queen's Health Systems, Hawaii Association for Justice, and Drug Policy Forum of Hawaii provided comments on this measure.

 

Your Committee has amended this measure by:

 

(1) Removing the provision that specifies that an informed consent agreement is not required for opioid therapy patients who are incapacitated and receiving treatment at a hospital under the supervision of a licensed health care provider;

 

(2) Changing its effective date to July 1, 2050, to facilitate further discussion; and

 

(3) Making technical, nonsubstantive amendments for clarity, consistency, and style.

 

Your Committee notes that the provision contained in Section 3 of this measure, which specified that an informed consent agreement is not required for incapacitated hospital patients, is outside of the scope of this measure's title.

 

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 807, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 807, S.D. 1, H.D. 1, and be referred to your Committees on Judiciary and Consumer Protection & Commerce.

 

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

JOHN M. MIZUNO, Chair